NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1386027068 M.D.
Verify on CMS → Abdullateef Abdulkareem, M.D.
Hematology & Oncology Physician in Lancaster, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
974
Medicare Part D claims · 141 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
74%
generic claims · 26% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Abdullateef Abdulkareem, M.D. filed 974 Medicare Part D claims in 2024 as a Hematology & Oncology Physician in Lancaster, Pennsylvania, prescribing 74% generic.
- 974
- Part D claims, 2024
- 74%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥74th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Abdullateef Abdulkareem, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1386027068), first enumerated 06/30/2015.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 974 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Abdullateef Abdulkareem, M.D.'s individual license status. Verify directly with the state medical board.
Source: PA-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1386027068 · Hematology & Oncology Physician
NPI-10 · ENUM-MID · TAX-MID · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1386027068
- ENUM-MID 2015
- TAX-MID 12K Hematology &
- RX-LIGHT 974
- BOOK-LIGHT 657 in Pennsylvania
- PHOTO-ENUM Sharon Li · 2015
Abdullateef Abdulkareem, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
974 ≥ 74th percentile 74% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Abdullateef Abdulkareem, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Abdullateef Abdulkareem, M.D.?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
974 10% vs specialty avg
Specialty distribution in Pennsylvania
How Hematology & Oncology Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1386027068 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/30/2015 |
Hospital and facility affiliations
Facilities where Abdullateef Abdulkareem, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Lancaster General Medical Group
Lancaster, PA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Abdullateef Abdulkareem, M.D.. To verify Abdullateef Abdulkareem, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Abdullateef Abdulkareem, M.D. - brand share 26.0%
Hematology & Oncology Physician average
26% brand-name claims vs 74% generic, on 974 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
974
Total Claims
$3.9M
Total Drug Cost
141
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,154.533
- Total Day Supply
- 28,421
- Brand vs Generic
- 26% brand / 74% generic
- Brand Drug Cost
- $3.5M
- Generic Drug Cost
- $439K
- Opioid Claims
- 18 (1.8% rate)
- Antibiotic Claims
- 33
Patient Demographics
- Average Patient Age
- 72.6 years
- Avg HCC Risk Score
- 2.15
- Gender Split
- 42% female / 58% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Abdullateef Abdulkareem, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Acyclovir
Acyclovir
114 claims
- Ondansetron Hcl
Ondansetron Hcl
88 claims
- Hydroxyurea
Hydroxyurea
53 claims
- Olanzapine
Olanzapine
51 claims
- Brukinsa
Brukinsa
48 claims
- Prednisone 41
Prednisone
41 claims
- Famotidine 38
Famotidine
38 claims
- Dexamethasone 35
Dexamethasone
35 claims
| Drug | Claims |
|---|---|
| Acyclovir | 114 |
| Ondansetron Hcl | 88 |
| Hydroxyurea | 53 |
| Olanzapine | 51 |
| Brukinsa Zanubrutinib | 48 |
| Prednisone | 41 |
| Famotidine | 38 |
| Dexamethasone | 35 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 26 |
| Bosulif Bosutinib | 24 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Abdullateef Abdulkareem, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider
Abdullateef Abdulkareem, M.D.'s 974 claims are above the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Abdulkareem, both outside Pennsylvania so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2015)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Abdulkareem.
One of 657 Hematology & Oncology Physician providers enrolled in Pennsylvania, 5 are shown here.
Dr. Charles Abrams
MD
Philadelphia, PA
Tala Achkar
Pittsburgh, PA
Dr. Monica Adedeji
MD, MPH
Hershey, PA
Dr. Giridhar Adiga
MD
Ephrata, PA
Dr. Christian Adonizio
MD
Danville, PA
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Abdullateef Abdulkareem, M.D.'s specialty? ▼
Abdullateef Abdulkareem, M.D. specializes in Hematology & Oncology Physician and practices in Lancaster, Pennsylvania. Credentials: M.D..
How much does Abdullateef Abdulkareem, M.D. prescribe under Medicare Part D? ▼
In 2024, Abdullateef Abdulkareem, M.D. wrote 974 Medicare Part D claims totaling $3.9M in drug costs for 141 beneficiaries.
Where is Abdullateef Abdulkareem, M.D. located? ▼
Abdullateef Abdulkareem, M.D. is located at 2102 HARRISBURG PIKE, Lancaster, PA, 17601. Phone: (717) 544-9400.
What is Abdullateef Abdulkareem, M.D.'s NPI number? ▼
Abdullateef Abdulkareem, M.D.'s National Provider Identifier (NPI) is 1386027068, issued on 06/30/2015.
Does Abdullateef Abdulkareem, M.D. prescribe more brand-name or generic drugs? ▼
Abdullateef Abdulkareem, M.D.'s prescribing is 26% brand-name and 74% generic drugs by claim count, with $3.5M in brand drug costs.
Does Abdullateef Abdulkareem, M.D. prescribe opioids? ▼
Yes, Abdullateef Abdulkareem, M.D. had 18 opioid claims in 2024 with an opioid prescribing rate of 1.8%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Abdullateef Abdulkareem, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Abdullateef Abdulkareem, M.D.'s most frequently prescribed drugs include Acyclovir, Ondansetron Hcl, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Abdullateef Abdulkareem, M.D. accept Medicare? ▼
Abdullateef Abdulkareem, M.D. appears in CMS Medicare data with 974 Part D claims and 141 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Abdullateef Abdulkareem, M.D.'s credentials? ▼
Abdullateef Abdulkareem, M.D.'s NPI is 1386027068 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.